NORMALIZATION OF ANTICANCER DRUG-DOSAGE USING BODY-WEIGHT AND SURFACE-AREA - IS IT WORTHWHILE - A REVIEW OF THEORETICAL AND PRACTICAL CONSIDERATIONS

被引:76
作者
REILLY, JJ [1 ]
WORKMAN, P [1 ]
机构
[1] UNIV GLASGOW,CANC RES CAMPAIGN,BEATSON LABS,DEPT MED ONCOL,GLASGOW G61 1BD,SCOTLAND
关键词
D O I
10.1007/BF00685883
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:411 / 418
页数:8
相关论文
共 51 条
[11]   Relations between age and weight and dosage of drugs [J].
Dawson, WT .
ANNALS OF INTERNAL MEDICINE, 1940, 13 (09) :1594-1615
[12]   A formula to estimate the approximate surface area if height and weight be known [J].
Du Bois, D ;
Du Bois, EF .
ARCHIVES OF INTERNAL MEDICINE, 1916, 17 (06) :863-871
[13]  
Du Bois EF, 1936, BASAL METABOLISM HLT
[14]  
EGORIN MJ, 1985, CANCER RES, V45, P6502
[15]  
FORFAR JO, 1978, TXB PAEDIATRICS
[16]  
FREIREICH EMIL J., 1966, CANCER CHEMOTHERAP REP, V50, P219
[17]   PHARMACOLOGY AND CLINICAL TOXICITY OF 4'-IODO-4'-DEOXYDOXORUBICIN - AN EXAMPLE OF SUCCESSFUL APPLICATION OF PHARMACOKINETICS TO DOSE ESCALATION IN PHASE-I TRIALS [J].
GIANNI, L ;
VIGANO, L ;
SURBONE, A ;
BALLINARI, D ;
CASALI, P ;
TARELLA, C ;
COLLINS, JM ;
BONADONNA, G .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (06) :469-477
[18]  
Gibson R.S., 1990, PRINCIPLES NUTR ASSE, P200
[19]   THE IMPACT OF PHARMACOKINETICALLY GUIDED DOSE ESCALATION STRATEGIES IN PHASE-I CLINICAL-TRIALS - CRITICAL-EVALUATION AND RECOMMENDATIONS FOR FUTURE STUDIES [J].
GRAHAM, MA ;
WORKMAN, P .
ANNALS OF ONCOLOGY, 1992, 3 (05) :339-347
[20]  
GROCHOW LB, 1990, J NATL CANCER I, V82, P323